Literature DB >> 15749243

Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism.

Sreenivasa R Chandana1, Michael E Behen, Csaba Juhász, Otto Muzik, Robert D Rothermel, Thomas J Mangner, Pulak K Chakraborty, Harry T Chugani, Diane C Chugani.   

Abstract

The role of serotonin in prenatal and postnatal brain development is well documented in the animal literature. In earlier studies using positron emission tomography (PET) with the tracer alpha[(11)C]methyl-l-tryptophan (AMT), we reported global and focal abnormalities of serotonin synthesis in children with autism. In the present study, we measured brain serotonin synthesis in a large group of autistic children (n = 117) with AMT PET and related these neuroimaging data to handedness and language function. Cortical AMT uptake abnormalities were objectively derived from small homotopic cortical regions using a predefined cutoff asymmetry threshold (>2 S.D. of normal asymmetry). Autistic children demonstrated several patterns of abnormal cortical involvement, including right cortical, left cortical, and absence of abnormal asymmetry. Global brain values for serotonin synthesis capacity (unidirectional uptake rate constant, K-complex) values were plotted as a function of age. K-complex values of autistic children with asymmetry or no asymmetry in cortical AMT uptake followed different developmental patterns, compared to that of a control group of non-autistic children. The autism groups, defined by presence or absence and side of cortical asymmetry, differed on a measure of language as well as handedness. Autistic children with left cortical AMT decreases showed a higher prevalence of severe language impairment, whereas those with right cortical decreases showed a higher prevalence of left and mixed handedness. Global as well as focal abnormally asymmetric development in the serotonergic system could lead to miswiring of the neural circuits specifying hemispheric specialization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749243     DOI: 10.1016/j.ijdevneu.2004.08.002

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  60 in total

1.  Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior.

Authors:  Georgianna G Gould; Julie G Hensler; Teresa F Burke; Robert H Benno; Emmanuel S Onaivi; Lynette C Daws
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

2.  Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Authors:  Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

3.  Enhancing the representation of functional connectivity networks by fusing multi-view information for autism spectrum disorder diagnosis.

Authors:  Huifang Huang; Xingdan Liu; Yan Jin; Seong-Whan Lee; Chong-Yaw Wee; Dinggang Shen
Journal:  Hum Brain Mapp       Date:  2018-10-25       Impact factor: 5.038

4.  Multi-task diagnosis for autism spectrum disorders using multi-modality features: A multi-center study.

Authors:  Jun Wang; Qian Wang; Jialin Peng; Dong Nie; Feng Zhao; Minjeong Kim; Han Zhang; Chong-Yaw Wee; Shitong Wang; Dinggang Shen
Journal:  Hum Brain Mapp       Date:  2017-03-27       Impact factor: 5.038

Review 5.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

Review 6.  From loci to networks and back again: anomalies in the study of autism.

Authors:  Ralph-Axel Müller
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

7.  A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome.

Authors:  Laura Greiss Hess; Sarah E Fitzpatrick; Danh V Nguyen; Yanjun Chen; Kimberly N Gaul; Andrea Schneider; Kerrie Lemons Chitwood; Marwa Abd Al Azaim Eldeeb; Jonathan Polussa; David Hessl; Susan Rivera; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2016-10       Impact factor: 2.225

8.  Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related potential measures of novelty processing in autism.

Authors:  Estate Sokhadze; Joshua Baruth; Allan Tasman; Mehreen Mansoor; Rajesh Ramaswamy; Lonnie Sears; Grace Mathai; Ayman El-Baz; Manuel F Casanova
Journal:  Appl Psychophysiol Biofeedback       Date:  2010-06

Review 9.  Review of targeted treatments in fragile X syndrome.

Authors:  Andrew Ligsay; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

10.  The serotonergic system: its role in pathogenesis and early developmental treatment of autism.

Authors:  D I Zafeiriou; A Ververi; E Vargiami
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.